Found: 16
Select item for more details and to access through your institution.
Predicting overall survival from tumor dynamics metrics using parametric statistical and machine learning models: application to patients with RET-altered solid tumors.
- Published in:
- Frontiers in Artificial Intelligence, 2024, p. 1, doi. 10.3389/frai.2024.1412865
- By:
- Publication type:
- Article
Effect of Hepatic Impairment on Cobimetinib Pharmacokinetics: The Complex Interplay Between Physiological Changes and Drug Characteristics.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 2, p. 144, doi. 10.1002/cpdd.847
- By:
- Publication type:
- Article
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 −) advanced/metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 2, p. 319, doi. 10.1007/s10549-022-06797-9
- By:
- Publication type:
- Article
Correction to: Application of a Novel ‘Make and Test in Parallel’ Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy Subjects.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Application of a Novel ‘Make and Test in Parallel’ Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy Subjects.
- Published in:
- Pharmaceutical Research, 2018, v. 35, n. 12, p. 1, doi. 10.1007/s11095-018-2516-0
- By:
- Publication type:
- Article
Effect of Microenvironmental pH Modulation on the Dissolution Rate and Oral Absorption of the Salt of a Weak Acid – Case Study of GDC-0810.
- Published in:
- Pharmaceutical Research, 2018, v. 35, n. 2, p. N.PAG, doi. 10.1007/s11095-018-2347-z
- By:
- Publication type:
- Article
A physiologically based pharmacokinetic (PBPK) approach to evaluate pharmacokinetics in patients with cancer.
- Published in:
- Biopharmaceutics & Drug Disposition, 2013, v. 34, n. 3, p. 141, doi. 10.1002/bdd.1830
- By:
- Publication type:
- Article
A Phase 1 study of GDC‐0134, a dual leucine zipper kinase inhibitor, in ALS.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 1, p. 50, doi. 10.1002/acn3.51491
- By:
- Publication type:
- Article
Impact of COVID‐19 on the Conduct and Design of Clinical Trials: IQ Consortium Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 1, p. 26, doi. 10.1002/cpt.3242
- By:
- Publication type:
- Article
Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Understanding CYP3A4 and P‐gp mediated drug–drug interactions through PBPK modeling – Case example of pralsetinib.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 660, doi. 10.1002/psp4.13114
- By:
- Publication type:
- Article
Exploring the Impact of Hepatic Impairment on Pralsetinib Pharmacokinetics.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 4, p. 564, doi. 10.3390/pharmaceutics16040564
- By:
- Publication type:
- Article
Exposure‐Response Relationships for Pralsetinib in Patients with RET‐Altered Thyroid Cancer or RET Fusion‐Positive Nonsmall Cell Lung Cancer.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 6, p. 685, doi. 10.1002/jcph.2409
- By:
- Publication type:
- Article
Effect of OATP1B1/1B3 Inhibitor GDC‐0810 on the Pharmacokinetics of Pravastatin and Coproporphyrin I/III in Healthy Female Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 11, p. 1427, doi. 10.1002/jcph.1261
- By:
- Publication type:
- Article
Impact of P‐gp inhibition on systemic exposure of pralsetinib and dosing considerations.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 6, p. 1, doi. 10.1111/cts.13818
- By:
- Publication type:
- Article
Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 3, p. 283, doi. 10.1007/s11523-022-00888-9
- By:
- Publication type:
- Article